GM07968
Fibroblast from Skin, Fetal
Description:
GAUCHER DISEASE, TYPE I
GLUCOSIDASE, ACID BETA; GBA
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Lysosomal Storage Diseases |
Class |
Disorders of Lipid Metabolism |
Biopsy Source
|
Fetal
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Fetal
|
Race
|
White
|
Ethnicity
|
JEWISH
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization after cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
5.39 |
Passage Frozen |
6 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
glucosylceramidase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.2.1.45 |
|
Gene |
GBA |
Chromosomal Location |
1q21 |
Allelic Variant 1 |
606463.0001; GAUCHER DISEASE, NEURONOPATHIC |
Identified Mutation |
LEU483PRO (LEU444PRO), 1448T>C; The leu444-to-pro (L444P) substitution in exon 10 of the GBA gene has been reported as resulting from a 1448T-C transition (Zimran et al., 1989) and from a 6433T-C transition (Latham et al., 1990), depending upon the reference sequence cited. This mutation has alternatively been referred to as LEU483PRO (Saranjam et al., 2013). |
|
Gene |
GBA |
Chromosomal Location |
1q21 |
Allelic Variant 2 |
606463.0001; GAUCHER DISEASE, NEURONOPATHIC |
Identified Mutation |
LEU483PRO (LEU444PRO), 1448T>C; The leu444-to-pro (L444P) substitution in exon 10 of the GBA gene has been reported as resulting from a 1448T-C transition (Zimran et al., 1989) and from a 6433T-C transition (Latham et al., 1990), depending upon the reference sequence cited. This mutation has alternatively been referred to as LEU483PRO (Saranjam et al., 2013). |
Remarks |
Fetal skin fibroblast culture; positive family history; deficient beta-glucosidase activity in cultured amniotic fluid cells; Jewish; donor subject is homozygous for a T>C transition at nucleotide 1448 (1448T>C) in exon 10 of the GBA gene resulting in a substitution at codon 444, Proline for Leucine [Leu444Pro (L444P)]; [codons are numbered from the first codon of the mature protein; the cDNA is numbered from the first initiating AUG] |
dbSNP |
dbSNP ID: 11073 |
Gene Cards |
GBA |
Gene Ontology |
GO:0004348 glucosylceramidase activity |
|
GO:0005764 lysosome |
|
GO:0005975 carbohydrate metabolism |
|
GO:0006665 sphingolipid metabolism |
|
GO:0007040 lysosome organization and biogenesis |
|
GO:0016020 membrane |
|
GO:0016798 hydrolase activity, acting on glycosyl bonds |
NCBI Gene |
Gene ID:2629 |
|
Gene ID:2630 |
NCBI GTR |
230800 GAUCHER DISEASE, TYPE I; GD1 |
|
606463 GLUCOSIDASE, BETA, ACID; GBA |
OMIM |
230800 GAUCHER DISEASE, TYPE I; GD1 |
|
606463 GLUCOSIDASE, BETA, ACID; GBA |
Omim Description |
ACID BETA-GLUCOSIDASE DEFICIENCY |
|
GAUCHER DISEASE, NONCEREBRAL JUVENILE |
|
GAUCHER DISEASE, TYPE I |
|
GBA DEFICIENCYGLUCOSIDASE, ACID BETA, INCLUDED; GBA, INCLUDED |
|
GD I |
|
GLUCOCEREBROSIDASE DEFICIENCY |
|
GLUCOCEREBROSIDASE PSEUDOGENE, INCLUDED; GBAP, INCLUDED |
Passage Frozen |
6 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Supplement |
- |
|
|